Silvercrest Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-8,831
| Closed | -$449K | – | 873 |
|
|
2025
Q4 | $449K | Sell |
8,831
-105,194
| -92% | -$5.38M | ﹤0.01% | 732 |
|
|
2025
Q3 | $6.33M | Sell |
114,025
-99,345
| -47% | -$5.82M | 0.04% | 398 |
|
|
2025
Q2 | $14.7M | Sell |
213,370
-8,048
| -4% | -$547K | 0.1% | 250 |
|
|
2025
Q1 | $15.4M | Buy |
221,418
+93,420
| +73% | +$7.72M | 0.11% | 226 |
|
|
2024
Q4 | $11M | Buy |
127,998
+3,881
| +3% | +$420K | 0.07% | 280 |
|
|
2024
Q3 | $14.8M | Buy |
124,117
+5,247
| +4% | +$700K | 0.1% | 217 |
|
|
2024
Q2 | $17M | Sell |
118,870
-15,190
| -11% | -$2.01M | 0.12% | 195 |
|
|
2024
Q1 | $17.2M | Buy |
134,060
+11,020
| +9% | +$1.31M | 0.12% | 191 |
|
|
2023
Q4 | $12.7M | Buy |
123,040
+17,733
| +17% | +$1.75M | 0.09% | 218 |
|
|
2023
Q3 | $9.58M | Sell |
105,307
-5,673
| -5% | -$500K | 0.07% | 238 |
|
|
2023
Q2 | $8.98M | Sell |
110,980
-8,840
| -7% | -$722K | 0.06% | 253 |
|
|
2023
Q1 | $9.53M | Sell |
119,820
-31,776
| -21% | -$2.25M | 0.07% | 236 |
|
|
2022
Q4 | $10.3M | Buy |
151,596
+32,166
| +27% | +$1.89M | 0.08% | 220 |
|
|
2022
Q3 | $5.95M | Sell |
119,430
-4,854
| -4% | -$260K | 0.05% | 300 |
|
|
2022
Q2 | $6.92M | Buy |
124,284
+13,284
| +12% | +$737K | 0.05% | 279 |
|
|
2022
Q1 | $6.16M | Buy |
111,000
+446
| +0.4% | +$22.9K | 0.04% | 342 |
|
|
2021
Q4 | $6.19M | Buy |
110,554
+42,428
| +62% | +$2.3M | 0.04% | 346 |
|
|
2021
Q3 | $3.27M | Buy |
68,126
+15,080
| +28% | +$729K | 0.02% | 436 |
|
|
2021
Q2 | $2.22M | Sell |
53,046
-330
| -0.6% | -$12.8K | 0.01% | 489 |
|
|
2021
Q1 | $1.8M | Sell |
53,376
-1,660
| -3% | -$59.1K | 0.01% | 504 |
|
|
2020
Q4 | $1.92M | Buy |
55,036
+2,574
| +5% | +$89K | 0.01% | 476 |
|
|
2020
Q3 | $1.82M | Buy |
52,462
+2,208
| +4% | +$73.6K | 0.02% | 466 |
|
|
2020
Q2 | $1.65M | Buy |
50,254
+1,504
| +3% | +$48K | 0.01% | 476 |
|
|
2020
Q1 | $1.47M | Sell |
48,750
-168
| -0.3% | -$5K | 0.02% | 460 |
|
|
2019
Q4 | $1.42M | Sell |
48,918
-310
| -0.6% | -$8.58K | 0.01% | 506 |
|
|
2019
Q3 | $1.27M | Buy |
49,228
+390
| +0.8% | +$9.86K | 0.01% | 517 |
|
|
2019
Q2 | $1.25M | Buy |
48,838
+476
| +1% | +$11.8K | 0.01% | 366 |
|
|
2019
Q1 | $1.26M | Sell |
48,362
-59,308
| -55% | -$1.46M | 0.01% | 360 |
|
|
2018
Q4 | $2.48M | Buy |
107,670
+480
| +0.4% | +$10.7K | 0.03% | 285 |
|
|
2018
Q3 | $2.53M | Sell |
107,190
-21,832
| -17% | -$533K | 0.02% | 300 |
|
|
2018
Q2 | $2.98M | Buy |
129,022
+2,524
| +2% | +$60K | 0.03% | 286 |
|
|
2018
Q1 | $3.12M | Buy |
126,498
+4,630
| +4% | +$122K | 0.03% | 283 |
|
|
2017
Q4 | $3.27M | Buy |
121,868
+3,550
| +3% | +$90.3K | 0.03% | 271 |
|
|
2017
Q3 | $2.85M | Buy |
118,318
+386
| +0.3% | +$8.72K | 0.03% | 277 |
|
|
2017
Q2 | $2.53M | Buy |
117,932
+11,430
| +11% | +$231K | 0.03% | 283 |
|
|
2017
Q1 | $1.82M | Buy |
106,502
+1,930
| +2% | +$33.6K | 0.02% | 307 |
|
|
2016
Q4 | $1.88M | Sell |
104,572
-18,450
| -15% | -$334K | 0.02% | 297 |
|
|
2016
Q3 | $2.56M | Buy |
123,022
+4,418
| +4% | +$110K | 0.03% | 275 |
|
|
2016
Q2 | $3.19M | Buy |
118,604
+20
| +0% | +$548 | 0.04% | 254 |
|
|
2016
Q1 | $3.21M | Sell |
118,584
-5,320
| -4% | -$143K | 0.04% | 245 |
|
|
2015
Q4 | $3.6M | Sell |
123,904
-3,960
| -3% | -$110K | 0.05% | 233 |
|
|
2015
Q3 | $3.47M | Sell |
127,864
-75,950
| -37% | -$2.15M | 0.05% | 220 |
|
|
2015
Q2 | $5.58M | Buy |
203,814
+11,344
| +6% | +$319K | 0.07% | 205 |
|
|
2015
Q1 | $5.14M | Sell |
192,470
-31,460
| -14% | -$724K | 0.07% | 201 |
|
|
2014
Q4 | $4.74M | Buy |
223,930
+1,090
| +0.5% | +$24.3K | 0.07% | 203 |
|
|
2014
Q3 | $5.31M | Buy |
222,840
+7,560
| +4% | +$174K | 0.08% | 198 |
|
|
2014
Q2 | $4.97M | Buy |
215,280
+2,000
| +0.9% | +$44.2K | 0.07% | 203 |
|
|
2014
Q1 | $4.87M | Buy |
213,280
+2,750
| +1% | +$58.6K | 0.08% | 190 |
|
|
2013
Q4 | $3.89M | Buy |
210,530
+27,380
| +15% | +$477K | 0.06% | 207 |
|
|
2013
Q3 | $3.1M | Buy |
183,150
+15,200
| +9% | +$256K | 0.06% | 217 |
|
|
2013
Q2 | $2.6M | Buy |
+167,950
| New | +$2.8M | 0.05% | 220 |
|
Other funds holding NVO
DAM
F
Silvercrest Asset Management's NVO Position: Q1 2026 in Review
Silvercrest Asset Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 8,831 shares — an estimated $449K sold.
Silvercrest Asset Management first reported a position in NVO in Q2 2013 and held it in 51 quarters. The position peaked at $17.2M in Q1 2024. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Silvercrest Asset Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- Silvercrest Asset Management sold 8,831 Novo Nordisk shares in Q1 2026, an estimated $449K.
- Silvercrest Asset Management first reported a position in Novo Nordisk in Q2 2013 and held it in 51 quarters.
- Silvercrest Asset Management's Novo Nordisk position peaked at $17.2M in Q1 2024.
- 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Silvercrest Asset Management's 13F filing for Q1 2026, filed 15 May 2026.